Axa S.A. Glycomimetics Inc Transaction History

Axa S.A.

$32.8 Billion
Q1 2024

A detailed history of Axa S.A. transactions in Glycomimetics Inc stock. As of the latest transaction made, Axa S.A. holds 1,587,741 shares of GLYC stock, worth $523,954. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,587,741

Previous 1,587,298 0.03%

Holding current value

$523,954

Previous $3.75 Million 27.15%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.55 - $3.49 $1,129 - $1,546	443 Added 0.03%	1,587,741 $4.76 Million
Q4 2023 Feb 14, 2024	SELL	$1.13 - $2.54 $43,391 - $97,536	-38,400 Reduced 2.36%	1,587,298 $3.75 Million
Q3 2023 Nov 14, 2023	SELL	$1.29 - $1.73 $7,496 - $10,053	-5,811 Reduced 0.36%	1,625,698 $2.44 Million
Q2 2023 Aug 14, 2023	BUY	$1.21 - $2.08 $27,162 - $46,691	22,448 Added 1.4%	1,631,509 $2.84 Million
Q1 2023 May 15, 2023	BUY	$1.25 - $4.05 $2.01 Million - $6.52 Million	1,609,061 New	1,609,061 $2.03 Million

Q2 2020 Aug 14, 2020	SELL	$2.06 - $3.76 $63,036 - $115,056	-30,600 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.83 - $5.41 $1.67 Million - $4.95 Million	-914,646 Reduced 96.76%	30,600 $70,000
Q4 2019 Feb 18, 2020	BUY	$4.03 - $6.5 $130,479 - $210,450	32,377 Added 3.55%	945,246 $5 Million
Q3 2019 Nov 14, 2019	SELL	$2.8 - $12.85 $49,509 - $227,213	-17,682 Reduced 1.9%	912,869 $3.93 Million
Q2 2019 Aug 13, 2019	BUY	$10.6 - $13.12 $57,314 - $70,939	5,407 Added 0.58%	930,551 $11.1 Million
Q1 2019 May 14, 2019	BUY	$9.96 - $13.44 $159,120 - $214,717	15,976 Added 1.76%	925,144 $11.5 Million
Q4 2018 Feb 13, 2019	BUY	$8.47 - $14.71 $1.55 Million - $2.7 Million	183,350 Added 25.26%	909,168 $8.61 Million
Q3 2018 Nov 08, 2018	BUY	$13.7 - $17.12 $1.55 Million - $1.93 Million	112,879 Added 18.42%	725,818 $10.5 Million
Q2 2018 Aug 13, 2018	BUY	$14.63 - $19.19 $1.53 Million - $2 Million	104,307 Added 20.51%	612,939 $9.89 Million
Q1 2018 May 14, 2018	SELL	$16.06 - $25.35 $37,612 - $59,369	-2,342 Reduced 0.46%	508,632 $8.26 Million
Q4 2017 Feb 13, 2018	BUY	$10.51 - $17.22 $5.37 Million - $8.8 Million	510,974	510,974 $8.58 Million

Others Institutions Holding GLYC

# of Institutions

Shares Held

36.8M

Call Options Held

969K

Put Options Held

636K

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $17.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account